Introduction Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. Bristol Myers Squibb focuses on areas such as oncology, cardiovascular, immunoscience, and fibrosis to develop therapies that address significant unmet medical needs. The company's research and development efforts are centered around discovering new drugs and advancing existing ones to improve patient outcomes. |
Disease Domain | Count |
---|---|
Neoplasms | 204 |
Immune System Diseases | 111 |
Hemic and Lymphatic Diseases | 92 |
Nervous System Diseases | 67 |
Endocrinology and Metabolic Disease | 54 |
Infectious Diseases | 44 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 187 |
Unknown | 47 |
Monoclonal antibody | 41 |
CAR-T | 17 |
Fusion protein | 8 |
Target |
Mechanism ACVR2A modulators [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date26 Mar 2024 |
Target |
Mechanism ALK inhibitors [+3] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date15 Nov 2023 |
Target- |
Mechanism SPECT |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date29 Sep 2023 |
Start Date30 Sep 2024 |
Sponsor / Collaborator |
Start Date01 Jul 2024 |
Sponsor / Collaborator |
Start Date01 Jul 2024 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Mitotane ( Steroid hormone receptor ) | Adrenocortical Carcinoma More | Approved |
Efavirenz ( HIV-1 RT ) | HIV Infections More | Approved |
Encainide Hydrochloride ( SCNA ) | Tachycardia, Ventricular More | Approved |
Ixabepilone ( Tubulin ) | Breast Cancer More | Approved |
Atazanavir Sulfate/Cobicistat ( CYP3A x HIV-1 pol ) | HIV Infections More | Approved |